Search
Search Results
##search.searchResults.foundPlural##
-
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1758PDF: 571HTML: 282 -
How I treat acute and persistent sickle cell pain
1927PDF: 1117HTML: 485 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3533PDF: 1177HTML: 4998Incidence age-standardized rates for HL across the Mediterranean basin: 201 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
723PDF: 465HTML: 6265 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
832PDF: 814HTML: 124 -
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
827PDF: 552HTML: 161 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2116PDF: 820HTML: 1639Figure 1: 304 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1576PDF: 1208HTML: 190 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3551PDF: 2411HTML: 1463 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1117PDF: 487HTML: 233 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7442PDF: 2421HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2631PDF: 943HTML: 3605 -







